Apixaban for stroke prevention in hemodialysis patients with nonvalvular atrial fibrillation

Affiliations

¹ Department of Medicine, Division of Nephrology, McGill University Health Center and Research Institute, Montreal, Quebec, Canada. Electronic address: thomas.mavrakanas@mcgill.ca.

Comment

Thomas A Mavrakanas. Kidney Int. 2023 Jun.

. 2023 Jun;103(6):1014-1017.

doi: 10.1016/j.kint.2023.03.027. Epub 2023 Apr 12.

¹ Department of Medicine, Division of Nephrology, McGill University Health Center and Research Institute, Montreal, Quebec, Canada. Electronic address: thomas.mavrakanas@mcgill.ca.

No abstract available

Keywords: apixaban; atrial fibrillation; bleeding; hemodialysis; stroke.

Comment on

Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
Pokorney SD, Chertow GM, Al-Khalidi HR, Gallup D, Dignacco P, Mussina K, Bansal N, Gadegbeku CA, Garcia DA, Garonzik S, Lopes RD, Mahaffey KW, Matsuda K, Middleton JP, Rymer JA, Sands GH, Thadhani R, Thomas KL, Washam JB, Winkelmayer WC, Granger CB; RENAL-AF Investigators. Pokorney SD, et al. Circulation. 2022 Dec 6;146(23):1735-1745. doi: 10.1161/CIRCULATIONAHA.121.054990. Epub 2022 Nov 6. Circulation. 2022. PMID: 36335914 Clinical Trial.
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study.
Reinecke H, Engelbertz C, Bauersachs R, Breithardt G, Echterhoff HH, Gerß J, Haeusler KG, Hewing B, Hoyer J, Juergensmeyer S, Klingenheben T, Knapp G, Christian Rump L, Schmidt-Guertler H, Wanner C, Kirchhof P, Goerlich D. Reinecke H, et al. Circulation. 2023 Jan 24;147(4):296-309. doi: 10.1161/CIRCULATIONAHA.122.062779. Epub 2022 Nov 6. Circulation. 2023. PMID: 36335915 Free PMC article. Clinical Trial.